Oncolytics Biotech annual shares outstanding
2024
2025
Oncolytics Biotech Shares Outstanding History (ONCY)
Oncolytics Biotech reported 108.0M shares outstanding at the end of fiscal 2025.
View full Oncolytics Biotech company overviewOncolytics Biotech annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 108.0M | 28.0M | +34.99% |
| 2024 | 2024-12-31 | 80.0M | — | — |
Oncolytics Biotech quarterly shares outstanding
Q4.24
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 124.6M | — | — |
| Q1 2026 | 2026-03-31 | 116.1M | — | — |
| Q4 2025 | 2025-12-31 | 108.0M | — | — |
| Q4 2024 | 2024-12-31 | 80.0M | — | — |
Oncolytics Biotech shares outstanding trends
Across the available reported history, Oncolytics Biotech's shares outstanding moved from 80.0M to 108.0M, a change of 28.0M. The latest reported quarter, Q2 2026, shows 124.6M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oncolytics Biotech filings at SEC.gov ↗